Bacillus subtilis deoxyribonucleic acid gyrase.
Bacillus subtilis 168 was shown to contain a deoxyribonucleic acid (DNA) gyrase activity which closely resembled those of the enzymes isolated from Escherichia coli and Micrococcus luteus in its enzymatic requirements, substrate specificity, and sensitivity to several antibiotics. The enzyme was purified from the wild type and nalidixic acid-resistant and novobiocin-resistant mutants of B. subtilis and was functionally characterized in vitro. The genetic loci nalA and novA but not novB were shown to code for portions of the functional gyrase. Enzyme from the antibiotic-resistant mutants was resistant to the drug in vitro. The most striking observation was the remarkable similarity between the B. subtilis enzyme and other DNA gyrases, especially with respect to the oxolinic acid-induced DNA cleavage in the presence of sodium dodecyl sulfate. All of the enzymes appeared to possess the same specificity of cutting sites regardless of the source or type of DNA used. This result implies that gyrase binding to DNA is highly specific.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D001412:Bacillus subtilis / Q000201:enzymology* / Q000235:genetics; D002874:Chromosome Mapping; D004250:DNA Topoisomerases, Type II / Q000378:metabolism*; D004269:DNA, Bacterial / Q000378:metabolism; D005796:Genes; D008274:Magnesium / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology; D010093:Oxolinic Acid / Q000494:pharmacology; D013379:Substrate Specificity
D004269:DNA, Bacterial; D009675:Novobiocin; D000255:Adenosine Triphosphate; D004250:DNA Topoisomerases, Type II; D008274:Magnesium; D010093:Oxolinic Acid